An illustrious line up

Feisal Nahaboo reveals the OMMG board.

Feisal Nahaboo, founder of the Overnight Multiple Merger Group (OMMG), has detailed the illustrious line up for his Executive and Strategic Boards. Comprising 20
highly sought-after and influential operators in diverse fields of business, this robust board clearly signals Feisal’s intent to make the Overnight Multiple Merger Model one of the leading business models of the future. All 20 Directors were approached and appointed within a 48-hour process. Collectively they form a 2-tier, high level management structure.

As Feisal says, “I’ve painstakingly built a powerhouse of strategic and visionary capabilities to steer the group into exciting new waters. Through the incredibly successful launch of Xeinadin and Alitam, the OMM (Overnight Multiple Merger) model is already proven to be an astounding success. It’s shaken the investment world into a new way of thinking. With this board of exceptional talent, I’m completely confident in the ability of the OMMG to further disrupt and innovate; offering new, more efficient ways of working in prominent industries, while reaping significant financial benefits for all involved.”

The board feature leading lights of the accountancy world, including and not limited, to Bob Stebbings, Mukesh Pandit, Arnold Wylie, Jim O’Donovan, Jim Baker and Mike Ogilvie. They are joined by luminaries of the pharmacy industry such as David McNally, Ray McSharry, Peter Weedle, and Sukhjit Gill. The Executive and Strategic boards reflect an important balance of key players in both the UK and Irish markets; Ireland being a gateway to Europe and beyond, allowing companies to capitalise on the significant opportunities available post Brexit.

‘A force of nature’: Feisal Nahaboo, the man behind the OMMG

With his signature energy and creative vision, Feisal established the OMM models in 2018. “Throughout my career, I’ve worked with some of the world greats – one of which was Dr Stephen Covey. They saw something in me and they always encouraged me to take my thinking to the next level,” explains Feisal. “With the OMMG I feel I’m achieving this goal, launching a brand new, dynamic business model of the future. One which offers the fastest way to build profitable, reputable and sizeable businesses overnight by headhunting the best operators in their respective industries.”

In 2018, in a move both unprecedented and unforeseen, Feisal founded Xeinadin, a 122-company accountancy merger overnight. This was followed by Alitam, a 200-strong pharmacy store merger just a year later. Alitam is set to be a Top 5 player, and has ambitions of FTSE 100 listing in the next five years. On the back of these successes, Feisal is readying the OMMG for its stellar stock market listing launch in 2022, backed by his own tireless determination, and that of his exemplary board.

The elite Executive Board will be responsible for the day-to-day running of the business, while the Non-Executive Board will focus on its strategic development. They will be strengthening the value proposition of the OMMG, acting as a support team for all subsequent OMM models and helping with their structure and development. Non-Executive Board members will also act as intermediaries in approaching, inspiring and encouraging potential entrants. Their diverse range of skillsets, spanning both the Accounting and Pharmacy worlds, more than equip them for this task.

The Executive Board in Full

OMMG Strategic Board